Softwr

Healthcare · head to head

Amwell vs Woebot Health

A

Amwell

Healthcare

Telehealth platform connecting patients with providers

From
$99/visit
Rated
-
Full reviewWebsite
Woebot Health logo

Woebot Health

Healthcare

Conversational CBT chatbot that withdrew from consumer distribution and now sells only to payers and providers

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Amwell listed on UK G-Cloud 14 at £6.25 per user for SilverCloud by Amwell, submitted directly by American Well Corporation UK Limited; Woebot Health the company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • They diverge on capability: Amwell covers Video Consultations, Woebot Health covers Scripted CBT dialogue.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Amwell and Woebot Health actually diverge.

Attributes where Amwell and Woebot Health differ
AttributeAmwellWoebot Health
Starting price$99/visitOn request
Pricing modelsubscriptionquote
PlatformsWeb, MobileiOS, Android, Web
Founded2002Unknown

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Amwell

  • Video Consultations
  • Phone Consultations
  • Mental Health Services
  • Prescription Services
  • Digital Prescriptions
  • EHR Systems
  • Health Plans
  • HIPAA

Only in Woebot Health

  • Scripted CBT dialogue
  • Mood tracking
  • Crisis routing
  • Between-session support
  • Payer deployment
  • Provider copilot positioning
  • Research licensing
  • Population reporting

What people use each for

The jobs each tool is most often brought in to do.

Amwell

  • Patient Carenot Woebot Health
  • Medical Recordsnot Woebot Health
  • Practice Managementnot Woebot Health
  • Telehealthnot Woebot Health

Woebot Health

  • A health plan wanting a low intensity behavioural health option for members on a waiting list for therapynot Amwell
  • A provider organisation offering structured between-session CBT practice to patients already in treatmentnot Amwell
  • A research group running a trial that needs a clinically scripted rather than generative conversational agent for safety reasonsnot Amwell
  • A payer targeting a specific population such as postpartum members where scripted CBT content already existsnot Amwell

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Amwell

  • Listed on UK G-Cloud 14 at £6.25 per user for SilverCloud by Amwell, submitted directly by American Well Corporation UK Limited

Woebot Health

  • The company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • It is not an FDA cleared treatment for any indication, so it cannot be positioned to members as therapy and cannot substitute for a covered behavioural health benefit.
  • The scripted, non-generative design that makes it safe also makes it feel rigid next to current conversational AI, and engagement drops off quickly once users hit the edges of the script.
  • Published evidence is short-horizon symptom change in selected populations, mostly young adults, with little evidence of durable benefit or effect at whole-population scale.
  • With consumer distribution gone, the remaining business depends on a small number of payer and provider contracts, so a buyer should assume real vendor continuity risk over a multi-year term.

Pricing, plan by plan

Amwell

$99/visit
  • On-Demand Visit$99/visit
    • 24/7 availability
    • Board-certified doctors
    • Digital prescriptions

Woebot Health

On request
  • Woebot for payers and providers$undefined/year
    • Contracted per member per month or as a population licence
    • Sold to health plans and provider organisations, not to employers or individuals
    • No consumer purchase route since the app closed in June 2025

Which should you pick?

Choose Amwell if

  • You need video consultations.
  • You work on Web, Mobile.
  • You also want phone consultations.
Amwell review

Choose Woebot Health if

  • You need scripted cbt dialogue.
  • You work on iOS, Android, Web.
  • You also want mood tracking.
Woebot Health review

Questions people ask

Is Amwell or Woebot Health better?
Neither clearly leads. Amwell starts at $99/visit and Woebot Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Amwell or Woebot Health?
Amwell starts at $99/visit and Woebot Health at On request.
Does Amwell or Woebot Health run on more platforms?
Amwell runs on Web, Mobile. Woebot Health runs on iOS, Android, Web.
What is Amwell best used for?
Amwell is most often used for patient care, medical records, practice management, telehealth. Of those, patient care and medical records are not what Woebot Health is typically brought in for.
What can Amwell do that Woebot Health cannot?
Amwell covers Video Consultations, Phone Consultations, Mental Health Services, Prescription Services. Woebot Health covers Scripted CBT dialogue, Mood tracking, Crisis routing, Between-session support.

Answered from the vendors’ own pages

Woebot Health: Is Woebot still available?

Not to consumers. The consumer app closed in June 2025. The company continues to offer the product to payers, providers and researchers.

Woebot Health: Is it FDA cleared?

No. It held Breakthrough Device designation but never obtained marketing authorisation, and the founder cited the cost of that pathway as the reason for closing the consumer app.

Woebot Health: Is it generative AI?

Historically no. The dialogue is clinician-written and rule-based, a deliberate safety choice that limits how naturally it converses.

Woebot Health: What does the evidence show?

Randomised studies reported reduced depressive symptoms over short periods in selected populations, notably young adults. That is symptom change in a trial, not demonstrated population outcomes.

Share

Related pages

More on Amwell

More on Woebot Health

Keep looking

Other head to heads